Insights

Rapid RTSM Build Atreo markets a rapid RTSM build from Kickoff to Go-Live in 1-2 weeks, suggesting a sales opportunity by offering expedited deployments to sponsors with tight timelines or early-phase trials seeking fast RTSM readiness.

Quality Quantified The hybrid testing approach promises unmatched testing coverage and time savings, offering a selling point to risk-averse stakeholders who value demonstrable quality and reduced validation risk in RTSM implementations.

Configurable Agility Post go-live configurability with changes at little to no cost indicates a value proposition for sponsors facing evolving trial designs or protocol amendments, presenting upsell potential for ongoing optimization services.

Strategic Partnerships Recent integration with N-Sideโ€™s Supply App signals openness to ecosystem partnerships, opening doors for co-sell opportunities with analytics and supply management vendors to deliver end-to-end trial visibility.

Growth Potential Revenue size and recent funding, plus a focused niche in clinical development SaaS, imply a scalable platform with prospects for larger sponsors or multi-study deployments as credibility and market reach expand.

Similar companies to Atreo.io

Atreo.io Tech Stack

Atreo.io uses 8 technology products and services including Amazon Web Services, HashiCorp Terraform, Docker, and more. Explore Atreo.io's tech stack below.

Atreo.io's Email Address Formats

Atreo.io uses at least 1 email format:
Atreo.io Email FormatsExamplePercentage
FLast@atreo.ioJDoe@atreo.io
100%

Frequently Asked Questions

What is Atreo.io's official website and social media links?

Minus sign iconPlus sign icon
Atreo.io's official website is atreo.io and has social profiles on LinkedIn and Crunchbase.

How much revenue does Atreo.io generate?

Minus sign iconPlus sign icon
As of July 2026, Atreo.io's annual revenue is estimated to be $25M - $50M.

What is Atreo.io's NAICS code?

Minus sign iconPlus sign icon
Atreo.io's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Atreo.io have currently?

Minus sign iconPlus sign icon
As of July 2026, Atreo.io has approximately 57 employees across 3 continents, including North America, Asia and Europe. Key team members include Head Of People: K. H., Head Of Client Services: K. F. and Strategic Advisor: L. V. Explore Atreo.io's employee directory with LeadIQ.

What industry does Atreo.io belong to?

Minus sign iconPlus sign icon
Atreo.io operates in the Pharmaceutical Manufacturing industry.

What technology does Atreo.io use?

Minus sign iconPlus sign icon
Atreo.io's tech stack includes Amazon Web Services, HashiCorp Terraform, Docker, CookieYes, Zendesk, Mailgun, Microsoft 365 and ZoomInfo.

What is Atreo.io's email format?

Minus sign iconPlus sign icon
Atreo.io's email format typically follows the pattern of FLast@atreo.io. Find more Atreo.io email formats with LeadIQ.

How much funding has Atreo.io raised to date?

Minus sign iconPlus sign icon
As of July 2026, Atreo.io has raised $5.8M in funding. The last funding round occurred on Jun 06, 2022 for $4M.

When was Atreo.io founded?

Minus sign iconPlus sign icon
Atreo.io was founded in 2021.
Atreo.io logo

Atreo.io

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Atreo.io is a pharmaceutical manufacturing company based in San Francisco, California, focusing on clinical development support through a next-generation Randomized Therapeutic Study Management (RTSM) platform. The firm emphasizes rapid system design and deployment, offering an expedited build process and ongoing system configurability to accommodate protocol needs and post-launch changes, with a claim of improved testing coverage and quality through modern architecture and testing practices. Its target customers are likely organizations engaged in clinical trials seeking streamlined RTSM delivery and greater visibility into trial management, aiming to reduce time to go-live and enhance operational agility. The company positions itself within the clinical development software space as a SaaS provider that emphasizes speed, prototyping, quality, and adaptability, and it operates from its San Francisco base with a relatively small to mid-sized team. A notable recent development includes a partnership announced in early 2025 to integrate its RTSM platform with N-SIDEโ€™s Supply App, expanding end-to-end clinical trial management capabilities for clients.

Section iconCompany Overview

Website
atreo.io
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2021
Employees
51-200

Section iconFunding & Financials

  • $5.8M

    Atreo.io has raised a total of $5.8M of funding over 2 rounds. Their latest funding round was raised on Jun 06, 2022 in the amount of $4M as a Pre Seed.

  • $25M - $50M

    Atreo.io's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.